References
- Baier G, Telford D, Giampa L et al. Molecular cloning and characterization of PKCθ, a human novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J. Biol. Chem.268, 4997–5004 (1993).
- Hayashi K, Altman A. Protein kinase C θ (PKCθ): a key player in T cell life and death. Pharmacol. Res.55, 537–544 (2007).
- Sun Z, Arendt CW, Ellmeier W et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature404, 402–407 (2000).
- Pfeifhofer C, Gruber T, Letschka T et al. Defective IgG2a/2b class switching in PKC α-/- mice. J. Immunol.176, 6004–6011 (2006).
- Berg-Brown NN, Gronski MA, Jones RG et al. PKCθ signals activation versus tolerance in vivo. J. Exp. Med.199, 743–752 (2004).
- Fu G, Hu J, Niederberger-Magnenat N et al. Protein Kinase C η is required for T cell activation and homeostatic proliferation. Sci. Signal.4, ra84 (2011).
- Marsland BJ, Kopf M. T-cell fate and function: PKC-θ and beyond. Trends Immunol.29, 179–185 (2008).
- Valenzuela JO, Iclozan C, Hossain MS et al. PKCθ is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. J. Clin. Invest.119, 3774–3786 (2009).
- Marsland BJ, Nembrini C, Grun K et al. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-θ signaling and promote autoimmune myocarditis. J. Immunol.178, 3466–3473 (2007).
- Coenen MJ, Trynka G, Heskamp S et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum. Mol. Genet.18, 4195–4203 (2009).
- Cooper JD, Smyth DJ, Smiles AM et al. Meta-analysis of genome-wide association study data identifies additional Type 1 diabetes risk loci. Nat. Genet.40, 1399–1401 (2008).
- Blay P, Astudillo A, Buesa JM et al. Protein kinase C θ is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clin. Cancer Res.10, 4089–4095 (2004).
- Baier G, Wagner J. PKC inhibitors: potential in T cell-dependent immune diseases. Curr. Opin. Cell Biol.21, 262–267 (2009).
- Cywin CL, Dahmann G, Prokopowicz AS 3rd et al. Discovery of potent and selective PKC-θ inhibitors. Bioorg. Med. Chem. Lett.17, 225–230 (2007).
- Mosyak L, Xu Z, Joseph-McCarthy D, Brooijmans N, Somers W, Chaudhary D. Structure-based optimization of PKCθ inhibitors. Biochem. Soc. Trans.35, 1027–1031 (2007).
- Friman S, Arns W, Nashan B et al. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized Phase II study in renal transplant recipients. Am. J. Transplant.11, 1444–1455 (2011).
- Skvara H, Dawid M, Kleyn E et al. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J. Clin. Invest.118, 3151–3159 (2008).
- Evenou JP, Wagner J, Zenke G et al. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation. J. Pharmacol. Exp. Ther.330, 792–801 (2009).
- Matz M, Weber W, Mashreghi MF et al. Effects of the new immunosuppressive agent AEB071 on human immune cells. Nephrol. Dial. Transplant.25, 2159–2167 (2010).
- Weckbecker G, Pally C, Beerli C et al. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720. Transpl. Int.23, 543–552 (2010).
- Gruber T, Hermann-Kleiter N, Pfeifhofer-Obermair C et al. PKC θ cooperates with PKC θ in alloimmune responses of T cells in vivo. Mol. Immunol.46, 2071–2079 (2009).
- Grakoui A, Bromley SK, Sumen C et al. The immunological synapse: a molecular machine controlling T cell activation. Science285, 221–227 (1999).
- Monks CR, Kupfer H, Tamir I, Barlow A, Kupfer A. Selective modulation of protein kinase C-θ during T-cell activation. Nature385, 83–86 (1997).
- Kong K-F, Yokosuka T, Canonigo-Balancio AJ, Isakov N, Saito T, Altman A. A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat. Immunol.12, 1105–1112 (2011).
- Zanin-Zhorov A, Ding Y, Kumari S et al. Protein kinase C-θ mediates negative feedback on regulatory T cell function. Science328, 372–376 (2010).